Elevated incidence of head and neck cancer in solid organ transplant recipients.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 31512806.
- Also identified by DOI 10.1002/hed.25937.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Solid organ transplant recipients are known to be at an increased risk of cancer development, but research on head and neck cancer in transplant recipients has been limited and prior risk assessments may not be accurate. A retrospective review using a national Veterans Administration database to query outpatient problem lists for ICD codes indicating solid organ transplant and subsequent diagnosis of head and neck cancer. In a study of 30 939 656 patients (37 969 solid organ transplants and 113 995 head and neck cancers), history of transplant significantly predicted head and neck cancer, with relative risks ranging from 1.85 (thyroid) to 2.91 (salivary gland). Worse overall survival (OS) was seen for head and neck cancer patients with prior transplants. In a large case-control study, prior transplant was a risk factor for head and neck cancer development and worse OS for head and neck cancer patients.
Medical subject headings
- Head and Neck Neoplasms
- Organ Transplantation